Krystn Hammond

Krystn Hammond

Vice President

New York Office  |   |   212.257.5820

Krystn has over ten years of experience advising pharmaceutical and life sciences clients on transactions and tax restructurings, including acquisitions, divestitures, spin-offs, and intellectual property migrations. Her experience spans across industry subsectors, including big pharma, biotech, medical device/diagnostics, generic, specialty, animal health, OTC/consumer, and services, with transaction sizes ranging from $50 million to in excess of $70 billion.

Most recently, Krystn was a Director in PwC’s Deals practice focused on life sciences and led the firm’s business development efforts for the sector in the New York metro region. Prior to joining the Deals practice, Krystn served banking and capital markets clients for three years in PwC’s assurance practice.

Krystn received a bachelor’s degree in Finance and a master’s degree in Accounting from Tulane University’s A.B. Freeman School of Business. She is a licensed CPA in the state of New York and a CFA charter holder.

Selected Transactions

HBT Labs
Acquired by
American Regent
August 2022